Copyright @2013     University of Illinois College of Medicine all rights reserved | LOGIN / LOGOUT

If you have questions, comments, or problems accessing this site, please E-mail the webmaster

Privacy Statement | Public Formal Grievance Procedures | Strategic Planning Document | Health Care Industry Conflict of Interest Guidelines

About | Admissions |Departments & Programs |Research |Student Services |Patient Services |News |Alumni and Friends

University of Illinois College of Medicine at Chicago >> Education, Departments & Programs >> Departments >> Research >> Organized Research Units >> IPRM

Institute for Personalized Respiratory Medicine (IPRM)

Director: Joe G.N. Garcia, MD

Co-Director: Viswanathan Natarajan, PhD

The mission of the Institute for Personalized Respiratory Medicine (IPRM) at the University of Illinois at Chicago (UIC) and University of Illinois Hospital & Health Sciences System in Chicago is to deliver personalized medicine to medically underserved populations afflicted with a variety of cardiopulmonary disorders. The overall goals of IPRM are to enhance understanding of cardiovascular and respiratory health and diseases through collaborative basic, translational and clinical investigation. The eventual outcome of these efforts is the development of novel strategies and therapies to improve care and health of the medically underserved. The focus of the IPRM includes lung disorders such as acute- and sub-acute lung injury, infectious lung disease, interstitial lung diseases (such as sarcoidosis and idiopathic pulmonary fibrosis), pulmonary hypertension, sickle cell lung disease, scleroderma, lung cancer, asthma, and environmental lung disorders. Additional efforts are devoted to cardiac disorders including cardiac sarcoidosis, heart failure and lung and cardiac transplantation complications. The IPRM supports research activities of graduate students, post-doctoral fellows (PhDs) and clinical fellows (MDs) and serves as the academic home for the nurturing of the physician scientists engaged in translational cardiopulmonary research in their successful transition to an independent scientist.